Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » CRO/CMO Services

CRO/CMO Services


The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

In association with goBalto, ChinaBio is making its proprietary list of over 240 China-based CROs and CMOs available at www.goBalto.com.  Companies known to ChinaBio are identified as "Sourced by ChinaBio" and companies for which ChinaBio has visited their faciities, met with senior management and reviewed the companies' capabilities are identified as "Reviewed by ChinaBio."  Please contact us for more information on our CRO/CMO consulting services.

Recent Articles

  Boehringer Ingelheim Opens $77 Million Shanghai Biologics CMO Plant; Establishes R&D Partnership with Peking University
  Mandarin Capital Pays $17 Million for Majority Stake in Italian CMO
  WuXi Biologics Signs Manufacturing Partnership MOU with Prima Biomed
  ASLAN Signs up JHL to Provide Process Development for Asthma Treatment
  Samsung Biologics Raises $2 Billion in Korean IPO
  FMD K&L Joins with iMEDGlobal in International CRO Merger
  WuXi AppTec Gains China Rights to AutoGenomics' Molecular Diagnostic Platform
  BioDuro Expands its Shanghai CRO Facility
  Shanghai Mab-Venture Raises $35 Million in Funding Led by Prosperico Venture
  CANbridge Uses Boehringer Ingelheim China to Manufacture Novel Biologic